For example, miR-29 (liver cancer), miR-130a (liver cancer), miR-212 (liver cancer), and miR-185 (breast and kidney cancers) are sensitive to TRAIL-induced apoptosis in these cancer cells, whereas miR-25 (liver cancer), miR-222 (liver and lung cancers), and miR-221 (lung, liver, and bladder cancers) are resistant to TRAIL-induced apoptosis [142]. This evidence concerns the gene TNFSF10 and kidney cancer.